A Case of Overlapping Autoimmune Syndrome

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Jun 6

PMID 38841030

Authors

Moses O Evbuomwan

Toyin Ingram

Nafisa Saleem

Affiliations

Soon will be listed here.

Abstract

Overlapping autoimmune disorders are used to describe the coexistence of more than one autoimmune disease in the same patient. Mixed connective tissue disease (MCTD) and anti-synthetase syndrome (ASS) are autoimmune diseases that manifest with pulmonary involvement, presenting as persistent dyspnea. The coexistence of both conditions in the same patient is extremely rare. We herein report a case of a 44-year-old female who was diagnosed with MCTD with features of ASS (anti-Jo-1 antibody) in the setting of rheumatoid arthritis (anti-cyclic citrullinated peptide (anti-CCP) antibody), which shows temporary breathing improvement following treatment with corticosteroid and mycophenolate mofetil. However, after the completion of mycophenolate mofetil, she was found to be anti-Jo-1 antibody negative and anti-CCP antibody positive. Our case emphasizes the need to recognize overlapping autoimmune conditions in patients with complex clinical features and presentations with the immediate application of a comprehensive diagnostic approach and tailored treatment strategies. Early diagnosis and aggressive treatment are crucial for achieving remission and preventing organ damage.

References

Poupon R . Autoimmune overlapping syndromes. Clin Liver Dis. 2003; 7(4):865-78. DOI: 10.1016/s1089-3261(03)00092-8. View

Ruegg C, Maurer B, Laube I, Scholtze D . Jo1-antisynthetase syndrome and severe interstitial lung disease with organising pneumonia on histopathology with favourable outcome on early combined treatment with corticosteroids, mycophenolate mofetil and rituximab. BMJ Case Rep. 2019; 12(9). PMC: 6747926. DOI: 10.1136/bcr-2019-231006. View

Witt L, Curran J, Strek M . The Diagnosis and Treatment of Antisynthetase Syndrome. Clin Pulm Med. 2016; 23(5):218-226. PMC: 5006392. DOI: 10.1097/CPM.0000000000000171. View

Sieradzka A, Naccini B, Fontana M . A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids. Eur J Case Rep Intern Med. 2022; 9(7):003324. PMC: 9426970. DOI: 10.12890/2022_003324. View

Ungprasert P, Crowson C, Chowdhary V, Ernste F, Moder K, Matteson E . Epidemiology of Mixed Connective Tissue Disease, 1985-2014: A Population-Based Study. Arthritis Care Res (Hoboken). 2016; 68(12):1843-1848. PMC: 5426802. DOI: 10.1002/acr.22872. View

Solomon J, Swigris J, Brown K . Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol. 2011; 37(1):100-9. PMC: 3676869. DOI: 10.1590/s1806-37132011000100015. View

Connors G, Christopher-Stine L, Oddis C, Danoff S . Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?. Chest. 2010; 138(6):1464-74. DOI: 10.1378/chest.10-0180. View

Shafique Ur Rehman M, Subhan M, Gulraiz S, Bibi R, Waqas M, Ishfaq A . Overlapping Autoimmune Diseases: A Case Report and Review of Eosinophilic Granulomatosis With Polyangiitis and Mixed Connective Tissue Disease. Cureus. 2023; 15(8):e43584. PMC: 10503782. DOI: 10.7759/cureus.43584. View

Gunnarsson R, Molberg O, Gilboe I, Gran J . The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis. 2011; 70(6):1047-51. DOI: 10.1136/ard.2010.143792. View

10.

Frikha F, Saidi N, Snoussi M, Ben Salah R, Ben Ayed M, Daoud E . [Antisynthetase syndrome: a report of four cases and literature review]. Rev Pneumol Clin. 2012; 68(6):351-60. DOI: 10.1016/j.pneumo.2012.07.002. View

11.

Tanaka Y, Kuwana M, Fujii T, Kameda H, Muro Y, Fujio K . 2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases. Mod Rheumatol. 2020; 31(1):29-33. DOI: 10.1080/14397595.2019.1709944. View